İlhan Hacıbekiroğlu

9PUBLICATIONS
161CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNutrigenomics and personalised nutritionIntensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study.

|Mar 23, 2026
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study.

Osman Sütcüoğlu, Orhun Akdoğan, İlknur Deliktaş Onur

|Nov 17, 2025
Real-world comparison of doxorubicin-ifosfamide versus gemcitabine-docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study.

Salih Tunbekici, Gokhan Sahin, Haydar Cagatay Yuksel

|Sep 19, 2025
Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group.

Gökhan Şahin, Esmanur Kaplan Tüzün, Halil G Güzel

|Feb 20, 2025
Prognostic Nutritional Index as a Biomarker in Metastatic Hormone-Sensitive Prostate Cancer: Impact on Survival and Treatment Optimization.

Muhammet Bekir Hacioglu, Ahmet Kucukarda, Ivo Gokmen

|Jan 25, 2025
Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach.

Hakan Şat Bozcuk, Leyla Sert, Muhammet Ali Kaplan

Pageof 2

Frequent Collaborators

3 joint publications

Elif Şahin

3 joint publications

Harun Muğlu

3 joint publications

Ahmet Bilici

2 joint publications

Nargiz Majidova